Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-06-27

FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)

View source ↗

Summary

FDA approved a supplemental application for HUMULIN N (insulin human) filed by Eli Lilly and Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Humulin N (insulin isophane (NPH))

Snippet

SUPPL AP for HUMULIN N (INSULIN HUMAN)